Search results
-
Mr Greg Jackson
-
Dr Ross Jackson
-
Professor Sir Stephen Jackson
The main focus of research in our lab is to better understand how cells detect DNA damage and signal its presence to the DNA repair, transcription and cell cycle machineries. We believe that a deeper knowledge of these pathways will yield a better...
-
Dr Catherine Lindon
... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...
-
Dr Athena Matakidou
... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...
-
Dr Mariann Bienz
... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...
-
Dr Dario Bressan
... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...
-
Dr Frank McCaughan
My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...
-
Professor Gillian Murphy
... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...
-
Dr James Nathan
Cellular mechanisms of oxygen and metabolite sensing: ...
-
Dr James Rudd
... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...
-
Ms Paola Marco
... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...
-
Dr Marisa Segal
... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...
-
Professor Simon Mendez-Ferrer
The Méndez-Ferrer laboratory research focuses on the regulation of the haematopoietic stem-cell niche in health and disease. Blood stem cells reside in specialised niches which allows them to self-renew, proliferate, differentiate and migrate according...
-
Dr Anna-Maria Shiarli
-
Dr Avgi Andreou
-
Miss Anita Balakrishnan
-
Miss Alicia Garcia Gimenez
-
Mr Ashley Grimmer
-
Dr Andrew Baker
-
Miss Annie Howitt
-
Mr Ahmed Mohammed
-
Dr Alexander Fulton
-
Ms Alison Hallett
-
Dr Adrian Ionescu
I currently work as a post-doctoral research associate at the Cavendish Laboratory, Department of Physics, University of Cambridge, in the Thin Film Magnetism (TFM) group with Prof. Crispin Barnes on an ERC International Training Network project,...
-
Dr Aisling Redmond
Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK...
-
Dr Fazlur Rahman Talukdar
I am spearheading a translational research initiative focused on developing circulating tumour DNA (ctDNA) based biomarkers derived from minimally invasive biospecimens, with the primary objective of early cancer detection and monitoring. I am a...
-
Professor Grant Stewart
Professor Stewart is an academic surgeon at the University of Cambridge, with a focus on developing and promoting surgery related clinical trials and translational research. Grant has a specific interest in optimising management of patients with...
-
Dr Hayley Woffendin
After many years working as a postdoctoral research scientist (Molecular Biologist) within the University and Wellcome Trust Sanger Institute, I have been Scientific Administrator and Graduate Student Administrator with the Department of Oncology Since...
-
Dr Helen Hatcher
Dr Hatcher is the Clinical and Regional lead for young people with cancer specialising in sarcomas and other rare cancers. She qualified in medicine at the University of Cambridge and has trained at the Royal Marsden Hospital in London. Her PhD and post...
-
Dr Hanna Najgebauer
Open Targets Postdoctoral Fellow responsible for the development of new algorithms and computational tools for scoring cancer in vitro models based on their clinical relevance and covered genomic heterogeneity observed in primary disease.
-
Mr Justin Davies
Justin Davies Clinical Director of Digestive Diseases and Consultant Colorectal Surgeon at Addenbrooke's Hospital, and an Associate Lecturer at the University of Cambridge. His thesis was written on molecular stool screening for colorectal cancer, and...
-
Dr Kate Fife
Dr Kate Fife is a consultant clinical oncologist at Addenbrooke's Hospital, Cambridge where she was appointed in 2001. Together with Prof Tim Eisen and Dr Athena Matakidou, she runs a large research focussed renal cancer clinic which is one of the...
-
Dr Myriam Ouberai
I am a Senior Research Associate at the Cambridge Nanoscience Centre where I have undertaken several interdisciplinary projects aiming to decipher the molecular processes involved in Parkinson’s disease or to improve the efficacy and safety of drugs to...
-
Mr Richard Moulange
-
Miss Anne Babbage
-
Dr Anne-Laure Vallier
(tbc)
-
Miss Anne Christin Machel
-
Dr Anne Roberts
(tbc)
-
Dr Tony Jackson
Proteomic approaches to plasma-membrane assemblies: Membrane proteins cluster together selectively as spatially-restricted, functionally integrated complexes. This can play an important role in many biological processes, including signal transduction....
-
Professor Tony Green
Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...
-
Dr Arianne Richard
-
Mrs Anne Omaolain
-
Dr Anne Warren
Responsible for providing histopathological support and tissue sampling and assessment for research projects of the urological malignancies research programme.
-
Ms Christine Anne Loreno
-
Mr Angelos Kolias
Angelos Kolias is a Clinical Senior Lecturer and Consultant Neurosurgeon in the Department of Clinical Neurosciences, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University,...
-
Dr Alex Samoshkin
I have been a Translational Technology Manager in the University of Cambridge since 2017. My primary role is to connect researchers in technology/physical sciences with clinicians and academics to develop new collaborative translational projects. I...
-
Mr Asif Jah
Mr Asif Jah ...
-
Dr Cedric Ghevaert
Cedric Gevaert graduated from the medical school of the University Libre de Bruxelles in 1997 and subsequently became a fellow of the Royal College of Physicians, London (2000). He specialised in Haematology and became a fellow of the Royal College of...
-
Dr Harry Bulstrode
I have recently secured a CRUK Pioneer Award to fund my research into oncolytic virus therapies specific to the glioma stem cell population. ...
-
Mr Harveer Dev
I am a CRUK Clinical Lecturer in the Early Detection Programme, and Honorary Speciality Registrar in Urology, with a research interest in genome stability and prostate cancer. ...
-
Professor Duncan Jodrell
I endeavour to integrate and optimise the pre-clinical development and science-led clinical application of novel therapies and novel therapeutic combinations, including first into man (phase I) and associated studies. My research goal is to identify...
-
Dr Kelly Fagan Robinson
Robinson’s research focuses on the senses, disability, communication and social access. It foregrounds the ways that individual histories, bodies, sensorial hierarchies, education, and experiences of formalised care can generate epistemic dissonances...
-
Professor Steve Charnock-Jones
My cancer related research is focused on the molecular mechanisms underlying the progression from endometriosis to clear cell ovarian cancer. Endometriosis is a relatively common condition affecting approximately 10% of women of child bearing age and...
-
Dr Steven Bell
I am an Epidemiologist based within the Precision Breast Cancer Institute , Department of Oncology at the University of Cambridge. At present my work utilises next-generation sequencing data alongside bioinformatic approaches to obtain insights...
-
Mr Steve Hawkins
-
Dr Steve Holmes
-
Professor Steven Ley
-
Ms Irene Jackson Sillah
-
Professor Suzanne Turner
... approaches. This work is conducted in collaboration with Dr Jackson Orem, executive director of the Uganda Cancer Institute in Kampala and ...
-
Dr Ali Amin Al Olama
My research has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate...
-
Mr Arqum Anwar
Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...
-
Dr Andreas Bender
... Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug ...
-
Mrs Abigail Redman
-
Dr Alvis Brazma
High throughput (microarray, sequencing) data analysis. Data integration. Cell cycle. I am in charge of running and developing the transcriptomics data repository ArrayExpress.
-
Dr Alejandra Bruna
We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...
-
Professor Antonis Antoniou
My main research interest is the development and application of statistical modelling techniques for addressing clinical questions, and the development of risk prediction tools which are used in clinical practice. ...
-
Dr Annalise Katz-Summercorn
Early detection in oesophageal adenocarcinoma